CD56+ NK cells from patients with non–small cell lung cancer (NSCLC) or squamous cell carcinoma (SCC) showed enhanced production of vascular endothelial growth factor (VEGF) and placental growth factor (PIGF) (108). This evidence concerns the gene VEGFA and squamous cell carcinoma.